FLO — Flowers Foods, Inc. · 2026-09-05 · Verdict: WATCH · Conviction 3
Price $6.45 (screen row, 2026-09-04 build; no live prices) · Mkt cap $1,368M (212.06M sh) · EV $3,001M (corrected; screen said $2,601M) · 6.4x guided FY26 adj. EBITDA / 10.0x guided EBIT · Forward FCF yield ~14-16% (screen said 23.3%) · Net debt $1,633M · ADV $48.3M · 53.8% off 52-week high Sources: 10-K filed 2026-02-25 (Items 1, 1A, 7), 10-Q filed 2026-08-20, DEF 14A filed 2026-04-14, 8-Ks 2026-04-07, 05-21, 06-05, 08-20, 08-28, Form 4s (12 of 55 filed in trailing 12m). No transcript in the bundle.
1. What the business actually does
Flowers is the second-largest packaged bakery producer in the United States, running 44 plants in 19 states and selling bread, buns, rolls, snacks and baking mixes under Nature's Own, Dave's Killer Bread, Canyon Bakehouse, Simple Mills, Wonder and Tastykake. Nature's Own is the best-selling loaf bread in the country at roughly $1.5 billion of estimated retail sales (Circana, 53 weeks ending 1/4/26). Distribution is direct-store-delivery through 4,274 independent-distributor territories, plus warehouse delivery for Simple Mills, which is entirely co-manufactured (all 10-K 2025, Item 1). The top ten customers were 57.7% of FY2025 sales and Walmart/Sam's Club alone 21.5% (10-K 2025, Item 1A).
2. Why it is mispriced — the edge case
There is one identifiable mechanical seller and it is dated. On May 21, 2026 the board reset the dividend from an annual $0.99 to $0.50, a 49% cut, after 95 consecutive quarterly dividends and a stated "historical trend" of annual increases (8-K 2026-05-21; 10-K 2025, Item 7). A cut like that ejects a name from dividend-growth mandates regardless of price. Two weeks later the independent presiding director resigned (8-K 2026-06-05), and on August 20 guidance was cut. The stock is 53.8% off its high with 12-1 momentum of -45.1%.
The edge is weaker than it looks. This is a $48 million average-daily-volume mid cap with no coverage gap, and the deterioration is proportionate to the price move rather than smaller than it. Management's own words are that Branded Retail volumes fell on "significant market share declines from increased marketplace competition" (10-Q Q2 FY26, MD&A). Losing share inside a category the company itself says "has experienced volume decreases in recent years" (10-K 2025, Item 1A) is not a temporary problem a forced seller is mispricing.
3. Unit economics and growth
Q2 FY26 (12 weeks to July 18, 2026): net sales -4.0% to $1.193 billion on price/mix +1.8% and volume -5.8%; Branded Retail -3.8% on price/mix +3.8% and volume -7.6% (8-K 2026-08-20, EX-99.1). The volume decline accelerated from -3.3% in Q1. Adjusted EBITDA fell 19.2% to $111.3 million, margin 9.3% against 11.1%. Production costs rose 40bp to 51.6% of sales as lower volumes de-levered labour and adjusted SD&A rose 140bp on freight, workforce and marketing, while ingredients helped, down 80bp to 27.1% on cheaper flour, sweeteners and eggs. The margin problem is volume absorption, not input inflation.
FY2025 adjusted EBITDA was about $535 million (proxy base of $341.8 million EBITDA plus the $193.8 million of comparability items in the 10-K, less the $0.4 million pension credit; DEF 14A 2026, Appendix A; 10-K 2025, Item 7). Revised FY26 guidance of $453-481 million is down 10-16% on a year with one fewer week. First-half adjusted EBITDA was already $270.3 million, so the guide implies $183-211 million over the remaining 24 weeks, or $91-105 million per 12-week quarter against the $111.3 million just delivered.
4. Balance sheet and capital allocation
The screen's enterprise value is wrong: it used only non-current long-term debt and missed the $399.9 million current portion. Long-term debt at July 18, 2026 was $1,686.2 million against $52.8 million of cash, so net debt is $1,633.5 million and EV is $3,001 million (10-Q Q2 FY26, balance sheet). Add $317.1 million of leases and leverage is 4.2x guided EBITDA rather than 3.5x. Equity of $1,323.5 million is entirely goodwill: cost in excess of net tangible assets is $2,012.6 million, so tangible book is about negative $690 million, and FY25 already carried a $136.0 million impairment of two regional brands.
The screen's 23.3% FCF yield is stale FY2025 arithmetic. On guidance, GAAP EPS of $0.64-0.74 on 213.5 million shares plus $165-170 million of D&A less $115-125 million of capex is roughly $195-215 million of free cash flow, a 14-16% yield. The reset dividend costs about $106 million, leaving $90-110 million a year for debt reduction; $70 million came off in the first half. Buybacks are nil, the 383,204 shares repurchased for $3.8 million were all tax withholding, and the share count grew 0.4%.
Three financing facts matter, all from the Q2 FY26 10-Q MD&A. The revolver was amended on April 6, 2026 to extend an existing covenant holiday through the quarter ending October 9, 2027 and to add a pricing tier for ratings falling to Ba2/BB or below. The $400 million 3.500% 2026 notes mature October 1, 2026 and will be repaid with a floating three-year term loan at SOFR plus 0.875% to 2.000%, raising that tranche's cost. And a post-quarter review of $102.2 million of spare parts could "result in a material change to the carrying value."
5. Management: said versus did
On May 21 the CEO cut the dividend to "prioritize meaningful debt reduction" and in the same release said "we are reaffirming guidance" of $465-495 million adjusted EBITDA (8-K 2026-05-21). Thirteen weeks later that came down to $453-481 million, sales guidance from $5.163-5.267 billion to $5.070-5.142 billion, and the CEO conceded conditions were "more difficult than we anticipated" (8-K 2026-08-20). Insider conviction is near absent: one open-market purchase in twelve months, CFO Scaglione buying 5,000 shares for $37,542 at $7.51 on 2026-06-08, against zero sales (Form 4, 2026-06-10). On August 28 the board tightened the advance-notice bylaws governing shareholder nominations (8-K 2026-08-28).
6. Valuation
Bear (35%): volume keeps falling 5%, revenue -3% a year, margin slips to 8.0% by 2029 for about $375 million EBITDA plus a spare-parts and goodwill write-down; 6.0x gives $2.25 billion EV and roughly $3.30 a share. Base (45%): decline moderates to -2% volume against +2% price, EBITDA holds near $470 million, net debt falls to $1.35 billion by 2028, 7.5x gives about $10 plus dividends. Bull (20%): the reorganisation and the end of ERP spend in FY2027 add net savings, Nature's Own and Simple Mills stabilise volume, EBITDA reaches $540 million at 8.5x, about $15.75. Probability-weighted $8.92, 38% above price, against a bear case 49% below it. Reverse DCF: at a 10% cost of equity, $6.45 implies about $200 million of free cash flow to equity shrinking roughly 4.5% a year in perpetuity, close to extrapolating the current -4.0% revenue rate forever.
7. Catalysts and timeline
October 1, 2026: the notes mature and the term loan is drawn, fixing the new rate. Around November 2026: Q3 results, the first clean read on the Nature's Own relaunch, the first quarter carrying the post-Q2 reorganisation, and the spare-parts review, which management expects to finish by year end. February 2027: FY27 guidance. The covenant holiday expires with the quarter ending October 9, 2027.
8. Risks and pre-registered kill criteria
- Branded Retail volume down more than 5% year over year in either of the next two reported quarters.
- Reported FY2026 adjusted EBITDA below $453 million, the low end of the revised guide.
- Net debt (long-term debt including current maturities, less cash) above $1.70 billion at any quarter end, or a spare-parts write-down above $40 million.
- Any further reduction to the $0.50 annual dividend rate.
Risks outside the criteria: Walmart at 21.5% of sales, store brands at roughly 35% of category units and gaining share since 2022, GLP-1 drugs named by the company as a demand risk, and $2.01 billion of goodwill against a $1.37 billion market cap.
9. Verdict and summary
WATCH, conviction 3. The forced seller is real and dated, the 49% dividend reset of May 21, 2026 mechanically ejecting a name that had paid 95 consecutive quarterly dividends and raised annually, and the screen misprices the business in both directions, missing $399.9 million of current debt in enterprise value while charging a GAAP EBIT that carried a $136.0 million non-cash brand impairment; corrected, it is 6.4x guided adjusted EBITDA on a 14-16% forward free cash flow yield rather than 15.0x and 23.3%. But the fall is proportionate rather than excessive: volume decline accelerated from -3.3% in Q1 to -5.8% in Q2 with Branded Retail down 7.6% on what management itself calls significant market share losses, guidance was cut thirteen weeks after being reaffirmed, and the revised guide still implies $91-105 million of quarterly adjusted EBITDA against the $111.3 million just delivered. Underneath sits 3.5x net leverage (4.2x with leases), negative tangible book against $2.01 billion of goodwill, a covenant holiday extended to October 2027, a pricing grid amended for a possible junk rating, a $400 million refinancing into floating rate debt on October 1, and a possible material write-down on $102.2 million of spare parts. Probability-weighted value of $8.92 is 38% above price but the bear case is 49% below it, and the only insider buying in twelve months is $37,542 by the CFO at a price 14% above today's. The Q3 print in November resolves the refinancing rate, the spare-parts review and the first evidence on whether volume is bottoming.
Research for discussion, not investment advice. Positions and sizing are the reader's decision.